Evidence
Int J Mol Sci. 2024 Jan 19;25(2):1231. doi: 10.3390/ijms25021231.
ABSTRACT
Late-onset Alzheimer’s disease is the leading cause of dementia worldwide, accounting for a growing burden of morbidity and mortality. Diagnosing Alzheimer’s disease before symptoms are established is clinically challenging, but would provide therapeutic windows for disease-modifying interventions. Blood biomarkers, including genetics, proteins and metabolites, are emerging as powerful predictors of Alzheimer’s disease at various timepoints within the disease course, including at the preclinical stage. In this review, we discuss recent advances in such blood biomarkers for determining disease risk. We highlight how leveraging polygenic risk scores, based on genome-wide association studies, can help stratify individuals along their risk profile. We summarize studies analyzing protein biomarkers, as well as report on recent proteomic- and metabolomic-based prediction models. Finally, we discuss how a combination of multi-omic blood biomarkers can potentially be used in memory clinics for diagnosis and to assess the dynamic risk an individual has for developing Alzheimer’s disease dementia.
PMID:38279230 | DOI:10.3390/ijms25021231
Add to Google Keep
Estimated reading time: 3 minute(s)
Latest: Psychiatryai.com #RAISR4D
Real-Time Evidence Search [Psychiatry]
AI Search [Andisearch.com]
AI Q/A [Aikko.com]
Multi-Omic Blood Biomarkers as Dynamic Risk Predictors in Late-Onset Alzheimer’s Disease
🌐 90 Days
VR Related Evidence Matrix
- Early Diagnosis of Alzheimer's Disease with Blood Test; Tempting but Challenging
- Present and future of Blood-Based biomarkers of Alzheimer's Disease: Beyond the classics
- Impact of genetic predisposition to late-onset neurodegenerative diseases on early life outcomes and brain structure
- Blood-Based Biomarkers for Early Alzheimer's Disease Diagnosis in Real-World Settings
- Advances in nanoprobes for molecular MRI of Alzheimer's disease
- Application of Suggestive Biomarkers in Dementia With Lewy Bodies With Masking of Typical Clinical Symptoms by Alzheimer Disease-type Pathology
- Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer's disease
- Alzheimer's Disease Diagnosis in the Preclinical Stage: Normal Aging or Dementia
- Controversial Past, Splendid Present, Unpredictable Future: A Brief Review of Alzheimer Disease History
- Induced pluripotent stem cell models as a tool to investigate and test fluid biomarkers in Alzheimer's disease and frontotemporal dementia
- Blood-based biomarkers in Alzheimer's disease - moving towards a new era of diagnostics
- The Biochemistry Behind Cognitive Decline: Biomarkers of Alzheimer's Disease
- Using blood transcriptome analysis for Alzheimer's disease diagnosis and patient stratification
- Symptoms and age of prodromal Alzheimer's disease in Down syndrome: a systematic review and meta-analysis
- Consensus on rapid screening for prodromal Alzheimer's disease in China
- The Association of Alzheimer's Disease-Related Blood-Based Biomarkers with Cognitive Screening Test Performance in the Congolese Population in Kinshasa
- New horizons in the diagnosis and management of Alzheimer's Disease in older adults
- Multiomics analysis to explore blood metabolite biomarkers in an Alzheimer's Disease Neuroimaging Initiative cohort
- Association of Plasma Markers of Alzheimer's Disease, Neurodegeneration, and Neuroinflammation with the Choroid Plexus Integrity in Aging
- Meeting report of the fifth annual workshop on Principles and Techniques for Improving Preclinical to Clinical Translation in Alzheimer's Disease Research
- Alzheimer's Disease and Suicide: An Integrative Literature Review
- Difference of Cerebrospinal Fluid Biomarkers and Neuropsychiatric Symptoms Profiles among Normal Cognition, Mild Cognitive Impairment, and Dementia Patient
- Analytical and clinical validation of Alzheimer's disease blood biomarkers with a focus on plasma p-tau217
- Modern Approaches to the Diagnosis of Cognitive Impairment and Alzheimer's Disease: A Narrative Literature Review
- Endo-lysosomal dysfunction in neurodegenerative diseases: opinion on current progress and future direction in the use of exosomes as biomarkers
- RNA therapeutics for neurological disease
- Benefits of Music Therapy in the Cognitive Impairments of Alzheimer's-Type Dementia: A Systematic Review
- Alzheimer's disease biomarker analysis using targeted mass spectrometry
- Whole genome-wide sequence analysis of long-lived families (Long-Life Family Study) identifies MTUS2 gene associated with late-onset Alzheimer's disease
- Ischemia-Reperfusion Programming of Alzheimer's Disease-Related Genes-A New Perspective on Brain Neurodegeneration after Cardiac Arrest
- Cell type-specific functions of Alzheimer's disease endocytic risk genes
- Artificial intelligence and open science in discovery of disease-modifying medicines for Alzheimer's disease
- Using Drosophila amyloid toxicity models to study Alzheimer's disease
- Biomarkers of Alzheimer's disease and neurodegeneration in dried blood spots-A new collection method for remote settings
- Exploring the potential of quercetin in Alzheimer's Disease: Pharmacodynamics, Pharmacokinetics, and Nanodelivery systems
- Cost-effectiveness comparison between blood biomarkers and conventional tests in Alzheimer's disease diagnosis
- Blood-based Biomarkers of Cerebral Small Vessel Disease
- Disentangling Sex-Dependent Effects of APOE on Diverse Trajectories of Cognitive Decline in Alzheimer's Disease
- The relationship between 11 different polygenic longevity scores, parental lifespan, and disease diagnosis in the UK Biobank
- Addition of inflammation-related biomarkers to the CAIDE model for risk prediction of all-cause dementia, Alzheimer's disease and vascular dementia in a prospective study
- The power of representation: Statistical analysis of diversity in US Alzheimer's disease genetics data
- Virus-induced brain pathology and the neuroinflammation-inflammation continuum: the neurochemists view
- Consumption of ultra-processed foods and risk for Alzheimer's disease: a systematic review
- Depressive Symptoms and Plasma Markers of Alzheimer's Disease and Neurodegeneration: A Coordinated Meta-Analysis of 8 Cohort Studies
- European intersocietal recommendations for the biomarker-based diagnosis of neurocognitive disorders
- The Relationship Between First Presenting Neuropsychiatric Symptoms in Older Adults and Autopsy-Confirmed Memory Disorders
- Exploitation of Autophagy Inducers in the Management of Dementia: A Systematic Review
- Predictors and outcomes of fluctuations in the clinical dementia rating scale
- Do microbes play a role in Alzheimer's disease?
- Arterial Aging and Cerebrovascular Function: Impact of Aerobic Exercise Training in Older Adults
- Subsequent correlated changes in complement component 3 and amyloid beta oligomers in the blood of patients with Alzheimer's disease
- Feasibility of Oral Function Evaluation According to Dementia Severity in Older Adults with Alzheimer's Disease
- Recent advances in understanding of sleep disorders and disturbances for dementia risk and prevention
- Mapping morbidity 10 years prior to a diagnosis of young onset Alzheimer's disease
- Psychedelics for Alzheimer's Disease-Related Dementia: Unveiling Therapeutic Possibilities and Pathways
- Shaping the future of preclinical development of successful disease-modifying drugs against Alzheimer's disease: a systematic review of tau propagation models
- CSF biomarkers of immune activation and Alzheimer's disease for predicting cognitive impairment risk in the elderly
- Metabolomics and the risk of dementia: a systematic review of prospective studies
- NLRP3 inflammasome signalling in Alzheimer's disease
- Impact of Sleep Disorders and Disturbed Sleep on Brain Health: A Scientific Statement From the American Heart Association
- Iatrogenic Alzheimer's disease in recipients of cadaveric pituitary-derived growth hormone
- Memantine versus Ginkgo biloba Extract: A Comparative Study on Cognitive Dysfunction Treatment in a Novel Rat Model
- Update on modifiable risk factors for Alzheimer's disease and related dementias
- The need for systems thinking to advance Alzheimer's disease research
Evidence Blueprint
Multi-Omic Blood Biomarkers as Dynamic Risk Predictors in Late-Onset Alzheimer’s Disease
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
Save Evidence Blueprint
Save as PDF
Multi-Omic Blood Biomarkers as Dynamic Risk Predictors in Late-Onset Alzheimer’s Disease
🌐 365 Days
VR Related Evidence Matrix
- Early Diagnosis of Alzheimer's Disease with Blood Test; Tempting but Challenging
- Present and future of Blood-Based biomarkers of Alzheimer's Disease: Beyond the classics
- Impact of genetic predisposition to late-onset neurodegenerative diseases on early life outcomes and brain structure
- Lysosomal polygenic risk is associated with the severity of neuropathology in Lewy body disease
- Blood-Based Biomarkers for Early Alzheimer's Disease Diagnosis in Real-World Settings
- Advances in nanoprobes for molecular MRI of Alzheimer's disease
- Blood biomarkers for Alzheimer's disease in clinical practice and trials
- Validating blood tests as a possible routine diagnostic assay of Alzheimer's disease
- Multi-ancestry meta-analysis and fine-mapping in Alzheimer's disease
- Effect of Pathway-Specific Polygenic Risk Scores for Alzheimer's Disease (AD) on Rate of Change in Cognitive Function and AD-Related Biomarkers Among Asymptomatic Individuals
- Application of Suggestive Biomarkers in Dementia With Lewy Bodies With Masking of Typical Clinical Symptoms by Alzheimer Disease-type Pathology
- Investigating the association between a history of depression and biomarkers of Alzheimer's disease, cerebrovascular disease, and neurodegeneration in patients with dementia
- Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer's disease
- Alzheimer's polygenic risk scores, APOE, Alzheimer's disease risk, and dementia-related blood biomarker levels in a population-based cohort study followed over 17 years
- Alzheimer's Disease Diagnosis in the Preclinical Stage: Normal Aging or Dementia
- Alzheimer Disease Biomarkers: Moving from CSF to Plasma for Reliable Detection of Amyloid and tau Pathology
- Controversial Past, Splendid Present, Unpredictable Future: A Brief Review of Alzheimer Disease History
- Induced pluripotent stem cell models as a tool to investigate and test fluid biomarkers in Alzheimer's disease and frontotemporal dementia
- Blood-based biomarkers in Alzheimer's disease - moving towards a new era of diagnostics
- Lysosomal Polygenic Burden Drives Cognitive Decline in Parkinson's Disease with Low Alzheimer Risk
- Alzheimer's Disease Biomarker Detection Using Field Effect Transistor-Based Biosensor
- The Biochemistry Behind Cognitive Decline: Biomarkers of Alzheimer's Disease
- Using blood transcriptome analysis for Alzheimer's disease diagnosis and patient stratification
- Symptoms and age of prodromal Alzheimer's disease in Down syndrome: a systematic review and meta-analysis
- A protein panel in cerebrospinal fluid for diagnostic and predictive assessment of Alzheimer's disease
- Anti-amyloid antibody treatments for Alzheimer's disease
- Multipredictor risk models for predicting individual risk of Alzheimer's disease
- Longitudinal changes in hippocampal texture from healthy aging to Alzheimer's disease
- Consensus on rapid screening for prodromal Alzheimer's disease in China
- CSF 14-3-3β is associated with progressive cognitive decline in Alzheimer's disease
- Multi-Modality, Multi-Dimensional Characterization of Pediatric Non-Alcoholic Fatty Liver Disease
- Report of the APOE4 National Institute on Aging/Alzheimer Disease Sequencing Project Consortium Working Group: Reducing APOE4 in Carriers is a Therapeutic Goal for Alzheimer's Disease
- The Association of Alzheimer's Disease-Related Blood-Based Biomarkers with Cognitive Screening Test Performance in the Congolese Population in Kinshasa
- New horizons in the diagnosis and management of Alzheimer's Disease in older adults
- Association between aspirin use and risk of dementia: a systematic review and meta-analysis
- A new diagnostic tool for brain disorders: extracellular vesicles derived from neuron, astrocyte, and oligodendrocyte
- Multiomics analysis to explore blood metabolite biomarkers in an Alzheimer's Disease Neuroimaging Initiative cohort
- Association of Plasma Markers of Alzheimer's Disease, Neurodegeneration, and Neuroinflammation with the Choroid Plexus Integrity in Aging
- Extracellular vesicle proteome unveils cathepsin B connection to Alzheimer's disease pathogenesis
- Meeting report of the fifth annual workshop on Principles and Techniques for Improving Preclinical to Clinical Translation in Alzheimer's Disease Research
- Lower mortality risk in APOE4 carriers with normal cognitive ageing
- Alzheimer's Disease and Suicide: An Integrative Literature Review
- Gut microbiome composition may be an indicator of preclinical Alzheimer's disease
- Next-generation proteomics technologies in Alzheimer's disease: from clinical research to routine diagnostics
- Difference of Cerebrospinal Fluid Biomarkers and Neuropsychiatric Symptoms Profiles among Normal Cognition, Mild Cognitive Impairment, and Dementia Patient
- Levels of Alzheimer's disease blood biomarkers are altered after food intake-A pilot intervention study in healthy adults
- Analytical and clinical validation of Alzheimer's disease blood biomarkers with a focus on plasma p-tau217
- Modern Approaches to the Diagnosis of Cognitive Impairment and Alzheimer's Disease: A Narrative Literature Review
- Endo-lysosomal dysfunction in neurodegenerative diseases: opinion on current progress and future direction in the use of exosomes as biomarkers
- Peripheral blood amyloid-β involved in the pathogenesis of Alzheimer's disease via impacting on peripheral innate immune cells
- The Early-Onset Alzheimer's Disease Whole-Genome Sequencing Project: Study design and methodology
- RNA therapeutics for neurological disease
- Genetics of Alzheimer's Disease in the African American Population
- The associations of socioeconomic status with incident dementia and Alzheimer's disease are modified by leucocyte telomere length: a population-based cohort study
- The role of peripheral inflammatory insults in Alzheimer's disease: a review and research roadmap
- Benefits of Music Therapy in the Cognitive Impairments of Alzheimer's-Type Dementia: A Systematic Review
- Towards a future where Alzheimer's disease pathology is stopped before the onset of dementia
- Alzheimer's disease biomarker analysis using targeted mass spectrometry
- Whole genome-wide sequence analysis of long-lived families (Long-Life Family Study) identifies MTUS2 gene associated with late-onset Alzheimer's disease
- CSF metabolites associated with biomarkers of Alzheimer's disease pathology
- Ischemia-Reperfusion Programming of Alzheimer's Disease-Related Genes-A New Perspective on Brain Neurodegeneration after Cardiac Arrest
- Amidst an amygdala renaissance in Alzheimer's disease
- Cell type-specific functions of Alzheimer's disease endocytic risk genes
- A Phenome-Wide Association Study (PheWAS) of Late Onset Alzheimer Disease Genetic Risk in Children of European Ancestry at Middle Childhood: Results from the ABCD Study